Australia markets closed

PODD Jul 2025 90.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
97.000.00 (0.00%)
As of 01:27PM EDT. Market open.
Full screen
Previous close97.00
Open97.00
Bid93.00
Ask102.00
Strike90.00
Expiry date2025-07-18
Day's range97.00 - 97.00
Contract rangeN/A
Volume1
Open interest1
  • Insider Monkey

    Insulet (PODD) Faces Increasing Competition

    ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The positive momentum in 2023 continued in the first quarter of 2024, the stocks surged on the expectation of a soft landing of the economy and a slowdown in rate […]

  • Zacks

    Insulet (PODD) Unveils Key Achievements for the Omnipod 5 System

    Insulet (PODD) debuts the Omnipod 5 AID system in France and announces new updates for the U.S. markets.

  • Business Wire

    Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands

    ACTON, Mass., June 20, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Omnipod 5, compatible with both Dexcom G6 and Abbott FreeStyle Libre 2 Plus continuous glucose monitor (CGM) sensors, is now fully available in the U.K. and the Netherlands for individuals aged two years and older with type 1 diabetes. Omnipod 5 is the first and only tubeless automated insulin del